ts2

How Tempus AI Uses Clinical and Molecular Data in Cancer Care—and What the Evidence Proves

They are not the same as proving that every Tempus tool, or the platform as a whole, makes patients live longer. At the diagnostic end, Tempus offers tissue and liquid-biopsy tests that look for ...
Gut

Coordinated cellular programmes distinguish responses to neoadjuvant PD-L1 blockade and potentiate combinatorial immunotherapy in ESCC

Background Programmed death ligand 1 (PD-L1) blockade offers new therapeutic options for oesophageal squamous cell carcinoma ...
finance.biggo

1,200 Autism Genes Converge Into Two Distinct Pathways in the Brain, Opening Door to Personalized Treatment

A new study has found that more than 1,200 known autism spectrum disorder (ASD) risk genes converge into two common molecular states in the brain.
Labroots

Using transcriptomic data to refine molecular interpretation in laboratory cancer testing

Explore how targeted RNA sequencing resolves hereditary cancer VUS, clarifies splicing effects, and strengthens pathogenic ...
Technology Networks

NGS Applications: Where Sequencing Is Used and Why

An overview of where next-generation sequencing is used, from whole-genome variant discovery to clinical liquid biopsy and single-cell transcriptomics.
Science

Transcriptome-based classification in mice with ASD-risk mutations

Autism spectrum disorder (ASD) is a neurodevelopmental condition with a strong genetic component. Large-scale human genetic studies have identified >1200 ASD-risk genes. We report a sex-balanced atlas ...